Karen Lewis, MS, MM, CGC, medical policy administrator and genetic counselor at Priority Health, said that providers are engaging in genetic testing, but they are doing so in "an uninformed fashion."
Karen Lewis, MS, MM, CGC, medical policy administrator and genetic counselor at Priority Health, said that providers are engaging in genetic testing, but they are doing so in “an uninformed fashion.” The challenge for providers is that the field is growing “exponentially,” and many providers often get information in “snippets.” Often, they do not have the time to do research to find out if a given test has “true clinical utility,” Lewis said, meaning, that it goes beyond being accurate and changes the way a physician makes treatment decisions.
Can genetic testing improve patient care and still lower costs? Yes, Lewis said, because over time, “we are able to identifying patients who can benefit from testing that has true clinical utility.” Lewis said she is trying to identify more people who can benefit from testing and eliminate those who have no benefit from testing.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More